11-immunopathology part 1

Upload: pixey55

Post on 02-Jun-2018

235 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/10/2019 11-Immunopathology Part 1

    1/32

    Dr. Samir Ayad1

  • 8/10/2019 11-Immunopathology Part 1

    2/32

    Dr. Samir Ayad

    Immunity

    Natural (non-specific) immunity:

    Inherited & do not depend on previous exposure

    (a) First line of defense: mechanical (skin), cilia in

    trachea and bronchi, nasal and gastric secretions

    (b) Second line of defense: lysozymes, complement

    and phagocytic cells

    Acquired (specific) immunity:

    Specific response following exposure to a particular

    antigen

    2

  • 8/10/2019 11-Immunopathology Part 1

    3/32

    Dr. Samir Ayad

    Essential features of immune system

    - Specificity: for one particular antigen

    - Diversity: can recognize different antigens

    - Memory: to previous antigens, responsible

    for rapid, higher and persistent

    secondary immune response

    - Recruitment:by releasing cytokines that recruit

    & activate other defense mechanisms

    3

  • 8/10/2019 11-Immunopathology Part 1

    4/32

    Dr. Samir Ayad

    Harmful Immune Reactions

    Immunopathology

    Three groups of diseases:(1) Hypersensitivity (as anaphylaxis)

    (2) Autoimmune (as SLE)

    (3) immunologic deficiency (congenital or

    acquired)

    4

  • 8/10/2019 11-Immunopathology Part 1

    5/32

    Dr. Samir Ayad

    Hypersensitivity

    Allergy- Abnormal exaggerated immune reactions resulting

    in tissue injury

    - Four types on the basis of mechanism of injury:

    Type I: immediate (anaphylactic)

    Type II: cytotoxicType III: immune complex

    Type IV: cell-mediated hypersensitivity

    5

  • 8/10/2019 11-Immunopathology Part 1

    6/32

    Dr. Samir Ayad

    Type I: Immediate (Anaphylactic) Reaction

    Mechanism:

    - 1st

    exposure to allergen stimulates IgEbinds tomast cell and blood basophils

    - On subsequent exposure, the allergen reacts with

    the fixed AB degranulation of mast cells

    release of histamine and others

    6

  • 8/10/2019 11-Immunopathology Part 1

    7/32Dr. Samir Ayad

    Activation of mast cell & the potent inflammatory mediators

    released

    7

  • 8/10/2019 11-Immunopathology Part 1

    8/32Dr. Samir Ayad

    Clinical Types:

    (1) Atopy- Local form (affecting one organ) e.g. urticaria

    (hives), allergic rhinitis, bronchial asthma

    - Response to ingested or inhaled environmentalallergens

    - Affects 10% of population

    - Strong familial predisposition

    8

  • 8/10/2019 11-Immunopathology Part 1

    9/32Dr. Samir Ayad

    Bronchial asthma, high power

    Numerous eosinophils are prominent.

    9

  • 8/10/2019 11-Immunopathology Part 1

    10/32Dr. Samir Ayad

    (2) Anaphylaxis

    - Systemic from release of vasoactive amines

    into circulation e.g. peripheral circulatory failure,

    shock, hypotension, even death

    - Follows injection of allergens e.g. serum, drugs(penicillin)

    10

  • 8/10/2019 11-Immunopathology Part 1

    11/32Dr. Samir Ayad

    Drug-induced urticaria: penicillin

    Large, urticarial wheals on the face, neck, and trunk withangiodema in the periorbital region.

    11

  • 8/10/2019 11-Immunopathology Part 1

    12/32Dr. Samir Ayad

    Type II: Cytotoxic Reaction

    & Antibody-mediated Reaction

    Mechanism:

    Specific antibody (IgG or IgM) reacts with cell

    membrane antigen, activates the complement

    resulting in cell lysis

    12

  • 8/10/2019 11-Immunopathology Part 1

    13/32Dr. Samir Ayad

    Clinical types

    Transfusion reaction due to blood incompatibility:

    AB in recipient serum reacts against antigen ontransfused RBCs

    Rh incompatibility:Maternal AB to fetal RBC antigen (Rh) cross the

    placenta (IgG)

    Autoimmune hemolytic anemia:

    Autoantibodies to RBCs

    13

    2

    3

    1

  • 8/10/2019 11-Immunopathology Part 1

    14/32Dr. Samir Ayad

    Type II hypersensitivity.

    Antibody- and

    complement-mediated red

    blood cell lysis due tocomplement activation and

    the formation of the C5b-9

    membrane attack complex

    (MAC).

    14

  • 8/10/2019 11-Immunopathology Part 1

    15/32Dr. Samir Ayad

    Myasthenia gravis:

    Autoantibodies against acetylcholine receptors

    at neuromuscular junction, compete withacetylcholine for the acetylcholine receptors,

    inhibiting synaptic transmission leading to

    profound muscle weakness.

    Graves disease:

    Autoantibodies to thyroid stimulating hormone

    receptors on follicular cells stimulation of cells

    15

    4

    5

  • 8/10/2019 11-Immunopathology Part 1

    16/32Dr. Samir Ayad

    Noncytotoxic antireceptor antibodies in Graves disease and

    myasthenia. The binding of the antibody to the TSH receptor

    in Graves disease results in hyperthyroidism, whereas the

    inhibition of synaptic transmission in myasthenia gravis leads

    to profound muscle weakness.16

  • 8/10/2019 11-Immunopathology Part 1

    17/32Dr. Samir Ayad

    Goodpastures syndrome:

    - Formation of AB (IgG) to antigens common

    in glomeruli & pulmonary basement membranes

    - AB reacts with basement membrane antigen

    activates complement resulting in:- Lung: hemorrhage, necrosis, fibrosis

    - Kidney: glomerulonephritis, fibrosis, failure

    17

    6

  • 8/10/2019 11-Immunopathology Part 1

    18/32Dr. Samir Ayad

    Antibody against glomerular basement membrane antigens inGoodpasture disease. The binding of antibody to antigens of

    basement membrane activates complement, thereby recruitingpolymorphonuclear leukocytes and provoking tissue injury.

    18

  • 8/10/2019 11-Immunopathology Part 1

    19/32Dr. Samir Ayad

    Type III: immune Complex Reaction

    Mechanism:- Reaction of AB (IgG or IgM) with antigen results

    in the formation of soluble immune complexes

    - deposition of immune complexes in various tissues

    - Activation of complement acute inflammation

    and tissue damage

    19

  • 8/10/2019 11-Immunopathology Part 1

    20/32Dr. Samir Ayad

    20

  • 8/10/2019 11-Immunopathology Part 1

    21/32Dr. Samir Ayad

    21

  • 8/10/2019 11-Immunopathology Part 1

    22/32

    Dr. Samir Ayad22

    Arthus phenomenon

  • 8/10/2019 11-Immunopathology Part 1

    23/32

    Dr. Samir Ayad

    Clinical types:

    (1) Systemic form:

    - serum sickness

    - rheumatoid arthritis

    - systemic lupus erythematosus

    (2) Local form:

    - pneumonitis that develops 6-8 hours after

    inhalation of moldy hay (Farmers lung) ormoldy cheese (Cheese makers lung)

    23

  • 8/10/2019 11-Immunopathology Part 1

    24/32

    Dr. Samir Ayad

    One form of hypersensitivity pneumonitis is known asfarmer's lung because the farmer inhales thermophilicactinomyces in moldy hay that set off the reaction.

    24

    Lung hypersensitivity pneumonitis microscopic

  • 8/10/2019 11-Immunopathology Part 1

    25/32

    Dr. Samir Ayad

    Lung, hypersensitivity pneumonitis, microscopic

    This is an example of hypersensitivity pneumonitis that canoccur when there is an inhaled organic dust that produces alocalized type III hypersensitivity (Arthus) reaction from

    antigen-antibody complexes. There are no major long-termcomplications.

    25

  • 8/10/2019 11-Immunopathology Part 1

    26/32

    Dr. Samir Ayad

    Type IV: Cell Mediated Hypersensitivity

    Type IV is mediated by T cells rather than antibodies

    Mechanism:

    Includes 2 types of reaction

    1- DTH: Delayed-type hypersensitivity:

    - Reaction is mediated by CD4 cells (antigen-

    specific memory T cells)

    2-T cell-mediated cytotoxicity:

    - Release of IL-2 for activation of CD8 and y-

    interferon for activation of macrophages 26

  • 8/10/2019 11-Immunopathology Part 1

    27/32

    Dr. Samir Ayad

    Granulomas, which are

    typical of type IVhypersensitivity, consist

    of epithelioid cells, giant

    cells, and lymphocytes.

    27

  • 8/10/2019 11-Immunopathology Part 1

    28/32

    Dr. Samir Ayad

    Clinical types:

    (1) contact dermatitis

    (2) Killing of tumors and virus infected cells

    (3) Transplant rejection

    28

  • 8/10/2019 11-Immunopathology Part 1

    29/32

    Dr. Samir Ayad29

    Contact Dermatitis

  • 8/10/2019 11-Immunopathology Part 1

    30/32

    Dr. Samir Ayad30

    Contact Dermatitis

  • 8/10/2019 11-Immunopathology Part 1

    31/32

    Dr. Samir Ayad

    Immune Mechanism of Tissue Injury

    Summary:Immune responses (humoral or cellular) to antigens

    (exogenous or endogenous) cause tissue damaging

    hypersensitivity reactions:

    Type I: Humoral AB (IgE) binds to antigens,

    releases vasoactive amines from mast cells &

    blood basophils.

    31

  • 8/10/2019 11-Immunopathology Part 1

    32/32

    Type II: Humoral AB (IgG, IgM) binds to antigen on

    cell surface, activates complement cell lysis

    Type III: Humoral AB (IgG, IgM) binds to antigen

    forming soluble immune complexes

    activates complement attracts neutrophils

    release of neutrophilic enzymes tissue

    damage

    Type IV: Antigen-specific CD4 memory cells

    recruit & activate CD8 and macrophages

    tissue damage32